Standard
A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways. / Druedahl, Louise C; Almarsdóttir, Anna Birna; Kälvemark Sporrong, Sofia; De Bruin, Marie Louise; Hoogland, Hans; Minssen, Timo; van de Weert, Marco; Kesselheim, Aaron S; Sarpatwari, Ameet.
I:
Nature Biotechnology, Bind 38, Nr. 11, 2020, s. 1253-1256.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Druedahl, LC, Almarsdóttir, AB, Kälvemark Sporrong, S, De Bruin, ML, Hoogland, H
, Minssen, T, van de Weert, M, Kesselheim, AS & Sarpatwari, A 2020, '
A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways',
Nature Biotechnology, bind 38, nr. 11, s. 1253-1256.
https://doi.org/10.1038/s41587-020-0717-7
APA
Druedahl, L. C., Almarsdóttir, A. B., Kälvemark Sporrong, S., De Bruin, M. L., Hoogland, H.
, Minssen, T., van de Weert, M., Kesselheim, A. S., & Sarpatwari, A. (2020).
A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways.
Nature Biotechnology,
38(11), 1253-1256.
https://doi.org/10.1038/s41587-020-0717-7
Vancouver
Druedahl LC, Almarsdóttir AB, Kälvemark Sporrong S, De Bruin ML, Hoogland H
, Minssen T o.a.
A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways.
Nature Biotechnology. 2020;38(11):1253-1256.
https://doi.org/10.1038/s41587-020-0717-7
Author
Druedahl, Louise C ; Almarsdóttir, Anna Birna ; Kälvemark Sporrong, Sofia ; De Bruin, Marie Louise ; Hoogland, Hans ; Minssen, Timo ; van de Weert, Marco ; Kesselheim, Aaron S ; Sarpatwari, Ameet. / A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways. I: Nature Biotechnology. 2020 ; Bind 38, Nr. 11. s. 1253-1256.
Bibtex
@article{3f758d7c1cc54739bb14a0b49c7b381e,
title = "A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways",
author = "Druedahl, {Louise C} and Almarsd{\'o}ttir, {Anna Birna} and {K{\"a}lvemark Sporrong}, Sofia and {De Bruin}, {Marie Louise} and Hans Hoogland and Timo Minssen and {van de Weert}, Marco and Kesselheim, {Aaron S} and Ameet Sarpatwari",
year = "2020",
doi = "10.1038/s41587-020-0717-7",
language = "English",
volume = "38",
pages = "1253--1256",
journal = "Nature Biotechnology",
issn = "1087-0156",
publisher = "nature publishing group",
number = "11",
}
RIS
TY - JOUR
T1 - A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways
AU - Druedahl, Louise C
AU - Almarsdóttir, Anna Birna
AU - Kälvemark Sporrong, Sofia
AU - De Bruin, Marie Louise
AU - Hoogland, Hans
AU - Minssen, Timo
AU - van de Weert, Marco
AU - Kesselheim, Aaron S
AU - Sarpatwari, Ameet
PY - 2020
Y1 - 2020
U2 - 10.1038/s41587-020-0717-7
DO - 10.1038/s41587-020-0717-7
M3 - Journal article
C2 - 33144720
VL - 38
SP - 1253
EP - 1256
JO - Nature Biotechnology
JF - Nature Biotechnology
SN - 1087-0156
IS - 11
ER -
